Region: Brazil

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2023

The reduction of the patent term for pharmaceuticals resulted in uncertainty for stakeholders in Brazil. However, new legislation designed to modernise the country’s patent system and foster the innovation ecosystem are paving the way to Brazil becoming an increasingly attractive jurisdiction.

25 August 2023

Featured in SEP/FRAND Hub

Brazil has become a prominent venue for SEP litigation, mainly due to the early remedies that courts provide, particularly in Rio de Janeiro. As a result, there is an increasing number of declaratory judgment suits being filed by implementers aiming to secure other venues. However, this tactic is not deterring patent assertion.

09 August 2023

Corporate IP executives, deal makers, brand leaders, policy experts and legal advisers will convene in São Paulo to share best practices and insights

22 July 2023

Almost 50 cases have arisen in which IP owners are asserting their rights to an extended timeframe, the outcomes of which will have major ramifications in Latin America’s largest economy

30 May 2023

Latin America’s largest country is playing an increasingly prominent role in SEP/FRAND disputes

17 February 2023

Superior Court of Justice affirms right of SEP owners to preliminary injunctions

17 January 2023

Move could see ‘temporary paralysis’ at INPI

12 January 2023

A similar, separate case this year may still trigger a change of course, however

06 January 2023

IAM looks back at some key stories from Brazil and Colombia over the last 12 months

29 December 2022

The election of Lula da Silva may have significant policy ramifications, including for patent professionals

08 December 2022